“Halobetasol 0.01%/Tazarotene 0.045% (HP/TAZ) Lotion for the Treatment of Plaque Psoriasis in Patients With 3-5% Body Surface Area” (2020) SKIN The Journal of Cutaneous Medicine, 4(6), p. s78. doi:10.25251/skin.4.supp.78.